Yahoo Web Search

Search results

1. • • Average price target from 3 ratings: $ 5.00
     Reference:

     Akebia Therapeutics Inc. Research & Ratings | AKBA | Barron's

2. People also ask

   Should you buy Akebia Therapeutics (Akba)?

   • Akebia Therapeutics (AKBA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. A company's changing earnings picture is at the core of the Zacks rating.

   All You Need to Know About Akebia Therapeutics (AKBA) Rating Upgra…

   finance.yahoo.com/news/know-akebia-therapeutics-akba-rating-160007320.html

   See all results for this question

   Why did Akebia Therapeutics (Akba) stock surge over 25% premarket?

   • Akebia Therapeutics ( NASDAQ: AKBA) shares surged over 25% premarket on Thursday after the U.S. Food and Drug Administration (FDA) approved its Vafseo (vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis for at least three months.

   Akebia stock jumps as FDA clears renal anemia therapy - Seeking Alpha

   seekingalpha.com/news/4084769-akebia-stock-jumps-as-fda-clears-renal-anemia-therapy

   See all results for this question

   Is akebia a biopharmaceutical company?

   • CAMBRIDGE, Mass. , Sept. 6, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today ...

   Akebia Therapeutics, Inc. (AKBA) - Stock Analysis

   stockanalysis.com/stocks/akba/

   See all results for this question

   When can we expect a profit from Akebia Therapeutics (Akba)?

   • Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. When Can We Expect A Profit From Akebia Therapeutics, Inc. (NASDAQ:AKBA)? Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is

   Akebia Therapeutics, Inc. (AKBA) Stock Price, News, Quote & History

   finance.yahoo.com/quote/AKBA

   See all results for this question

3. finance.yahoo.com › news › know-akebia-therapeuticsAll You Need to Know About Akebia Therapeutics (AKBA) Rating ...

   finance.yahoo.com › news › know-akebia-therapeutics

   • Cached

   Jun 2, 2023 · Akebia Therapeutics (AKBA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy).

4. www.zacks.com › stock › researchShould I buy Akebia Therapeutics (AKBA) - Zacks

   www.zacks.com › stock › research

   • Cached

   5 days ago · Zacks' proprietary data indicates that Akebia Therapeutics, Inc. is currently rated as a Zacks Rank 4 and we are expecting a below average return from the AKBA shares relative to the market in...

5. www.zacks.com › stock › newsAll You Need to Know About Akebia Therapeutics (AKBA) Rating ...

   www.zacks.com › stock › news

   • Cached

   Jun 2, 2023 · Better trading starts here. Read More. Akebia Therapeutics ( AKBA - Free Report) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in...

6. finance.yahoo.com › quote › AKBAAkebia Therapeutics, Inc. (AKBA) Stock Price, News, Quote ...

   finance.yahoo.com › quote › AKBA

   • Cached

   Find the latest Akebia Therapeutics, Inc. (AKBA) stock quote, history, news and other vital information to help you with your stock trading and investing.

7. simplywall.st › nasdaq-akba › akebia-therapeuticsAkebia Therapeutics NasdaqCM:AKBA Stock Report - Simply Wall St

   simplywall.st › nasdaq-akba › akebia-therapeutics

   • Cached

   5 days ago · Research Akebia Therapeutics' (Nasdaq:AKBA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.

8. stockanalysis.com › stocks › akbaAkebia Therapeutics, Inc. (AKBA) - Stock Analysis

   stockanalysis.com › stocks › akba

   • Cached

   3 days ago · CAMBRIDGE, Mass. , May 23, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, tod... 1 day ago - PRNewsWire. Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference.

9. seekingalpha.com › news › 4084769-akebia-stock-jumpsAkebia stock jumps as FDA clears renal anemia therapy

   seekingalpha.com › news › 4084769-akebia-stock-jumps

   Mar 28, 2024 · Akebia Therapeutics ( NASDAQ: AKBA) shares surged over 25% premarket on Thursday after the U.S. Food and Drug Administration (FDA) approved its Vafseo (vadadustat) tablets for the treatment...